Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells

Spinal cord injury (SCI) is an intractable and worldwide difficult medical challenge with limited treatments. Neural stem/progenitor cell (NS/PC) transplantation derived from fetal tissues or embryonic stem cells (ESCs) has demonstrated therapeutic effects via replacement of lost neurons and severed...

Full description

Saved in:
Bibliographic Details
Main Authors: Junhao Deng, Yiling Zhang, Yong Xie, Licheng Zhang, Peifu Tang
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2018/5653787
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553192443871232
author Junhao Deng
Yiling Zhang
Yong Xie
Licheng Zhang
Peifu Tang
author_facet Junhao Deng
Yiling Zhang
Yong Xie
Licheng Zhang
Peifu Tang
author_sort Junhao Deng
collection DOAJ
description Spinal cord injury (SCI) is an intractable and worldwide difficult medical challenge with limited treatments. Neural stem/progenitor cell (NS/PC) transplantation derived from fetal tissues or embryonic stem cells (ESCs) has demonstrated therapeutic effects via replacement of lost neurons and severed axons and creation of permissive microenvironment to promote repair of spinal cord and axon regeneration but causes ethnical concerns and immunological rejections as well. Thus, the implementation of induced pluripotent stem cells (iPSCs), which can be generated from adult somatic cells and differentiated into NS/PCs, provides an effective alternation in the treatment of SCI. However, as researches further deepen, there is accumulating evidence that the use of iPSC-derived NS/PCs shows mounting concerns of safety, especially the tumorigenicity. This review discusses the tumorigenicity of iPSC-derived NS/PCs focusing on the two different routes of tumorigenicity (teratomas and true tumors) and underlying mechanisms behind them, as well as possible solutions to circumvent them.
format Article
id doaj-art-53f3263471034e83b0aef2c943ead617
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-53f3263471034e83b0aef2c943ead6172025-02-03T05:55:19ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/56537875653787Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor CellsJunhao Deng0Yiling Zhang1Yong Xie2Licheng Zhang3Peifu Tang4Department of Orthopaedics, Chinese PLA General Hospital, No. 28 Fuxin Road, Beijing 100853, ChinaDepartment of Orthopaedics, Chinese PLA General Hospital, No. 28 Fuxin Road, Beijing 100853, ChinaDepartment of Orthopaedics, Chinese PLA General Hospital, No. 28 Fuxin Road, Beijing 100853, ChinaDepartment of Orthopaedics, Chinese PLA General Hospital, No. 28 Fuxin Road, Beijing 100853, ChinaDepartment of Orthopaedics, Chinese PLA General Hospital, No. 28 Fuxin Road, Beijing 100853, ChinaSpinal cord injury (SCI) is an intractable and worldwide difficult medical challenge with limited treatments. Neural stem/progenitor cell (NS/PC) transplantation derived from fetal tissues or embryonic stem cells (ESCs) has demonstrated therapeutic effects via replacement of lost neurons and severed axons and creation of permissive microenvironment to promote repair of spinal cord and axon regeneration but causes ethnical concerns and immunological rejections as well. Thus, the implementation of induced pluripotent stem cells (iPSCs), which can be generated from adult somatic cells and differentiated into NS/PCs, provides an effective alternation in the treatment of SCI. However, as researches further deepen, there is accumulating evidence that the use of iPSC-derived NS/PCs shows mounting concerns of safety, especially the tumorigenicity. This review discusses the tumorigenicity of iPSC-derived NS/PCs focusing on the two different routes of tumorigenicity (teratomas and true tumors) and underlying mechanisms behind them, as well as possible solutions to circumvent them.http://dx.doi.org/10.1155/2018/5653787
spellingShingle Junhao Deng
Yiling Zhang
Yong Xie
Licheng Zhang
Peifu Tang
Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
Stem Cells International
title Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
title_full Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
title_fullStr Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
title_full_unstemmed Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
title_short Cell Transplantation for Spinal Cord Injury: Tumorigenicity of Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cells
title_sort cell transplantation for spinal cord injury tumorigenicity of induced pluripotent stem cell derived neural stem progenitor cells
url http://dx.doi.org/10.1155/2018/5653787
work_keys_str_mv AT junhaodeng celltransplantationforspinalcordinjurytumorigenicityofinducedpluripotentstemcellderivedneuralstemprogenitorcells
AT yilingzhang celltransplantationforspinalcordinjurytumorigenicityofinducedpluripotentstemcellderivedneuralstemprogenitorcells
AT yongxie celltransplantationforspinalcordinjurytumorigenicityofinducedpluripotentstemcellderivedneuralstemprogenitorcells
AT lichengzhang celltransplantationforspinalcordinjurytumorigenicityofinducedpluripotentstemcellderivedneuralstemprogenitorcells
AT peifutang celltransplantationforspinalcordinjurytumorigenicityofinducedpluripotentstemcellderivedneuralstemprogenitorcells